Resources

This document highlights the health impact of a variety of medical devices and health technologies in use around the world, such as SoloShot syringes, HEATmarker Vaccine Vial Monitors, Nifty Feeding Cups, Uniject injection systems, and safe water devices. Including innovations that have been produced at a scale of million and billions of units as well as more recent product introductions addressing critical global health needs are featured.

Urbanization in India has led to rapidly changing and diverse health needs, requiring adaptive and responsive urban health systems. However, despite initiatives such as National Urban Health Mission, dedicated health grants under Fifteenth Finance Commission, and Pradhan Mantri Ayushman Bharat Health Infrastructure Mission, persistent systemic challenges, including low community awareness of primary health services, fragmented governance across multiple departments, and weak community structures, continue to hinder comprehensive health care delivery. Existing community platforms have not sufficiently evolved to align with newer comprehensive primary health care initiatives at urban health facilities, including Urban Primary Health Centres (UPHCs) and Urban Ayushman Arogya Mandirs (UAAMs), resulting in limited uptake of services and inadequate responses to emerging public health threats. To address this gap, the National Health Mission (NHM) established Mahila Arogya Samitis (MAS) and Jan Arogya Samitis (JAS), though variably functional, offer a critical opportunity for participatory governance. This project seeks to activate and strengthen MAS and JAS in Bokaro, Jharkhand, through a systems-design approach that fosters convergence with Urban Local Bodies, establishes clear linkages and escalation pathways, and enables these community institutions to play an effective role in local health governance and community development.

Cholera remains a growing global public health threat, and the WHO-endorsed Controlled Temperature Chain (CTC) offers a practical way to improve access to oral cholera vaccines in high-risk, low-resource settings. This guidance brief describes how CTC allows eligible oral cholera vaccines to be stored and transported outside the standard 2–8°C cold chain for defined periods, reducing logistical barriers and enabling faster, more equitable delivery. Drawing on implementation experience from Bangladesh, Mozambique, and Zambia, the document outlines operational requirements, safety considerations, and key lessons learned, demonstrating that CTC can be safely applied to increase vaccination coverage, reduce costs, and support effective cholera outbreak prevention and response.

This is a simple, Excel-based tool for assessing and comparing costs of human papillomavirus (HPV) vaccination programs with each HPV vaccine product available in the global market. It aims to help national-level policymakers specifically in middle-income countries compare products and estimate vaccination program costs for different HPV vaccines, exploring up to four different vaccine options at a time. The tool calculates cold chain volume and costs annually and for a total period of five years. Cost estimates are composed of vaccine cost (i.e., vaccine and supplies procurement and international shipping) and vaccination program costs (i.e., vaccine cost and cost of delivery).It is important to note that cost is only one consideration when selecting an HPV vaccine product, and users involved in decision-making around new vaccine introduction/switch or product selection should always consider other dimensions as well. This model is meant to provide insights into the potential costs of alternative product choices and should not replace detailed budget planning once a product has been selected.A user guide is included in the file on a tab labeled “READ ME FIRST” which provides detailed instructions on how to use the tool and interpret the results. The tool is available to download in multiple languages. Please be sure to check out this six-minute tutorial video, which is in English, with French and Spanish subtitled versions also available. If you have additional questions or need support, contact PATH’s Health Economics & Outcomes Research team: HEOR@path.org.NOTE: Please refer to this web page for the most up-to-date version of the calculator, which is periodically updated to reflect the evolving vaccine landscape.

This fact sheet describes PATH's technical assistance work with low- and middle-income vaccine manufacturers and the Sustaining Vaccine Manufacturing program. It provides an overview of how we work and what we do, our capabilities, our successes, and how to work with us.